|
Rationale:
- Because patients will not be eating, they can be prone to developing hypoglycemia; educating patients on early symptoms may
prevent serious neuroglycopenia.
- Patients may be better prepared for surgery if they understand what their management plan will be and how they may be able
to avoid serious complications.
- The preoperative medical assessment provides patients with an opportunity to have their diabetes management reviewed and an
attempt to improve glycemic control.
|
|
Evidence:
- In a prospective cohort study of 280 patients with diabetes, those who received automated self-care assessment calls with
nursing phone call follow-up had fewer symptoms of hypo- or hyperglycemia (P<0.001) (60).
- In a case-control study of 21 patients who had severe hypoglycemia, patients were found to have less knowledge about diabetes
than those who did not experience severe hypoglycemia. The investigators concluded that patients' lack of knowledge about
the symptoms and signs of hypoglycemia is strongly associated with development of hypoglycemia (61).
- A randomized, controlled trial of patients with HbA1C levels >8.5% were randomly assigned to receive an intensive education program with structured curriculum or educational material.
HbA1C levels fell equally in both groups (-2.0%) at 12 months (P<0.001) (62).
- In a randomized, controlled trial of 170 patients with type 2 diabetes, patients were randomly assigned to either individual
or group educational settings. Both groups in the study had similar improvements in knowledge, BMI, health-related quality
of life and reduction in HbA1C compared to baseline. HbA1C level at baseline fell from 8.5% ± 1.8% to 6.5 ± 0.8% at 6 months (63).
- A technical review discusses the importance of diabetes self-management education for the hospitalized patient (49).
|
|
Comments:
- Patient education and perioperative management may be facilitated by a team approach including teaching competent adult patients
about elements of self-management while hospitalized.
|
| FAQs |
|
|
|
Melanie E. Mabrey, MSN, ACNP, BC-ADM, is a consultant and speaker for Sanofi-Aventis Pharmaceuticals. Nadia A. Khan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Susan E. Spratt, MD, is a consultant and speaker for Sanofi Aventis and Novo Nordisk. William A. Ghali, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device
manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships
with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|